Current status and analysis of medical treatment for benign prostatic hyperplasia in special clinic for elderly in China
10.3760/cma.j.issn.0254-9026.2010.03.021
- VernacularTitle:中国11城市老年科门诊良性前列腺增生患者药物治疗的现状及分析
- Author:
Xin WANG
;
Jianye WANG
;
Ming LIU
;
Pulin YU
;
Chuanfang ZHANG
;
Zhenqiu SUN
;
Yaqun ZHANG
;
Honghai WANG
- Publication Type:Journal Article
- Keywords:
Benign prostatic hyperplasia;
Questionnaires;
Drug utilization review;
Prostate-specific antigen
- From:
Chinese Journal of Geriatrics
2010;29(3):246-249
- CountryChina
- Language:Chinese
-
Abstract:
Objective To realize and analyze the current status of medical treatment for benign prostatic hyperplasia in special clinic for elderly in China.Methods The informations were gathered from 34 clinics for elderly located in 11 Chinese cities from February 2008 to September 2008.First, all male patients who visited the clinic were inquired about their history of benign prostatic hyperplasia , and then 1000 benign prostatic hyperplasia patients who were receiving medical treatment were selected to finish a detailed questionnaire and to get several examinations for benign prostatic hyperplasia.Results Among the 1000 patients, 774 completely finished the questionnaire, patients with middle or severe international prostate symptom score (IPSS) and with high volume of prostate occupied a large proportion.Medical treatments included the combined therapy of α-blockers plus 5α reductase inhibitors (45.48 %), α-blockers (36.30%), 5α reductase inhibitors (13.05 %) and other medicines (including phytotherapeutic agents and traditional medicines, 5.17%).Conclusions Nowadays in China, as to the prescription for benign prostatic hyperplasia in the clinic for elderly presents, doctors only concentrate on the improvement of symptoms, whereas ignore the progression of the disease.There is still a considerable gap between real medical treatment and international guidelines.Therefore, improvements of medical treatment are still needed in the future clinical practice.
